Parathyroid hormone (1-34) prevents cartilage degradation andpreserves subchondral bone micro-architecture in guinea pigs with spontaneous osteoarthritis

Osteoarthritis and Cartilage

Volumn 22, Issue 11, 2014, Pages 1869-1877

  Yan, J Y ^a   Tian, F M ^b   Wang, W Y ^b   Cheng, Y ^b   Song, H P ^b   Zhang, Y Z ^a   Zhang, L ^a,b  

^a HEBEI MEDICAL UNIVERSITY   (China)

^b HEBEI UNITED UNIVERSITY   (China)

Author keywords

Cartilage; Micro CT; Osteoarthritis; PTH (1 34); Subchondral bone

Indexed keywords

COLLAGEN TYPE 2; COLLAGENASE 3; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR 1; PARATHYROID HORMONE[1-34]; SCLEROSTIN; PARATHYROID HORMONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE STRUCTURE; CARTILAGE; CARTILAGE DEGENERATION; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; GUINEA PIG; HISTOLOGY; IMMUNOHISTOCHEMISTRY; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOARTHRITIS; OSTEOARTHRITIS RESEARCH SOCIETY INTERNATIONAL; PROTEIN EXPRESSION; TRABECULAR BONE; ANIMAL; ARTICULAR CARTILAGE; DISEASE MODEL; DRUG EFFECTS; PATHOLOGY; PROCEDURES; RADIOGRAPHY;

ANIMALS; CARTILAGE, ARTICULAR; DISEASE MODELS, ANIMAL; FEMALE; GUINEA PIGS; IMMUNOHISTOCHEMISTRY; OSTEOARTHRITIS; PARATHYROID HORMONE; X-RAY MICROTOMOGRAPHY;

EID: 84908309743     PISSN: 10634584     EISSN: 15229653     Source Type: Journal    
DOI: 10.1016/j.joca.2014.07.013     Document Type: Article

References (36)

1. Bailey A.J., Mansell J.P. Do subchondral bone changes exacerbate or precede articular cartilage destruction in osteoarthritis of the elderly?. Gerontology 1997, 43(5):296-304.
2. Ding M., Odgaard A., Hvid I. Changes in the three-dimensional microstructure of human tibial cancellous bone in early osteoarthritis. JBone Joint Surg Br 2003, 85(6):906-912.
3. Goldring M.B., Goldring S.R. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann N Y Acad Sci 2010, 1192:230-237.
4. Bobinac D., Marinovic M., Bazdulj E., Cvijanovic O., Celic T., Maric I., et al. Microstructural alterations of femoral head articular cartilage and subchondral bone in osteoarthritis and osteoporosis. Osteoarthritis Cartilage 2013, 21(11):1724-1730.
5. Cox L.G., van Donkelaar C.C., van Rietbergen B., Emans P.J., Ito K. Alterations to the subchondral bone architecture during osteoarthritis: bone adaptation vs endochondral bone formation. Osteoarthritis Cartilage 2013, 21(2):331-338.
6. Hayami T., Pickarski M., Zhuo Y., Wesolowski G.A., Rodan G.A., le Duong T. Characterization of articular cartilage and sub-chondral bone changes in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. Bone 2006, 38(2):234-243.
7. Lombardi G., Di Somma C., Rubino M., Faggiano A., Vuolo L., Guerra E., et al. The roles of parathyroid hormone in bone remodeling: prospects for novel therapeutics. JEndocrinol Invest 2011, 34(7 Suppl):18-22.
8. Zhang L., Takahashi H.E., Inoue J., Tanizawa T., Endo N., Yamamoto N., et al. Effects of intermittent administration of low dose human PTH (1-34) on cancellous and cortical bone of lumbar vertebral bodies on adult beagles. Bone 1997, 21(6):501-506.
9. Podbesek R., Edouard C., Meunier P.J., Parsons J.A., Reeve J., Stevenson R.W., et al. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 1983, 112(3):1000-1006.
10. Hock J.M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. JBone Miner Res 1992, 7(1):65-72.
11. Uzawa T., Hori M., Ejiri S., Ozawa H. Comparison of the effects of intermittent and continuous administration of human parathyroid hormone (1-34) on rat bone. Bone 1995, 16(4):477-484.
12. Chang J.K., Chang L.H., Hung S.H., Wu S.C., Lee H.Y., Lin Y.S., et al. Parathyroid hormone 1-34 inhibits terminal differentiation of human articular chondrocytes and osteoarthritis progression in rats. Arthritis Rheumatol 2009, 60(10):3049-3060.
13. Orth P., Cucchiarini M., Zurakowski D., Menger M.D., Kohn D.M., Madry H. Parathyroid hormone [1-34] improves articular cartilage surface architecture and integration and subchondral bone reconstitution in osteochondral defects invivo. Osteoarthritis Cartilage 2013, 21(4):614-624.
14. Bendele A.M. Animal models of osteoarthritis. JMusculoskelet Neuronal Interact 2001, 1(4):363-376.
15. Arunakul M., Tochigi Y., Goetz J.E., Diestelmeier B.W., Heiner A.D., Rudert J., et al. Replication of chronic abnormal cartilage loading by medial meniscus destabilization for modeling osteoarthritis in the rabbit knee invivo. JOrthop Res 2013, 31(10):1555-1560.
16. Mohan G., Perilli E., Parkinson I.H., Humphries J.M., Fazzalari N.L., Kuliwaba J.S. Pre-emptive, early, and delayed alendronate treatment in a rat model of knee osteoarthritis: effect on subchondral trabecular bone microarchitecture and cartilage degradation of the tibia, bone/cartilage turnover, and joint discomfort. Osteoarthritis Cartilage 2013, 21(10):1595-1604.
17. Mapp P.I., Sagar D.R., Ashraf S., Burston J.J., Suri S., Chapman V., et al. Differences in structural and pain phenotypes in the sodium monoiodoacetate and meniscal transection models of osteoarthritis. Osteoarthritis Cartilage 2013, 21(9):1336-1345.
18. Cheng T., Zhang L., Fu X., Wang W., Xu H., Song H., et al. The potential protective effects of calcitonin involved in coordinating chondrocyte response, extracellular matrix, and subchondral trabecular bone in experimental osteoarthritis. Connect Tissue Res 2013, 54(2):139-146.
19. Suri S., Walsh D.A. Osteochondral alterations in osteoarthritis. Bone 2012, 51(2):204-211.
20. Bendele A.M., Hulman J.F. Effects of body weight restriction on the development and progression of spontaneous osteoarthritis in guinea pigs. Arthritis Rheum 1991, 34(9):1180-1184.
21. Wei L., de Bri E., Lundberg A., Svensson O. Mechanical load and primary guinea pig osteoarthrosis. Acta Orthop Scand 1998, 69(4):351-357.
22. Huebner J.L., Hanes M.A., Beekman B., TeKoppele J.M., Kraus V.B. Acomparative analysis of bone and cartilage metabolism in two strains of guinea-pig with varying degrees of naturally occurring osteoarthritis. Osteoarthritis Cartilage 2002, 10(10):758-767.
23. Bendele A.M., Hulman J.F. Spontaneous cartilage degeneration in guinea pigs. Arthritis Rheum 1988, 31(4):561-565.
24. Krause C., Korchynskyi O., de Rooij K.E., Weidauer S.E., de Gorter D.J., van Bezooijen R.L., et al. Distinct modes of inhibition by sclerostin on bone morphogenetic protein and Wnt signaling pathways. JBiol Chem 2010, 285(53):41614-41626.
25. Semenov M., Tamai K., He X. SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor. JBiol Chem 2005, 280(29):26770-26775.
26. Chan B.Y., Fuller E.S., Russell A.K., Smith S.M., Smith M.M., Jackson M.T., et al. Increased chondrocyte sclerostin may protect against cartilage degradation in osteoarthritis. Osteoarthritis Cartilage 2011, 19(7):874-885.
27. van Bezooijen R.L., Bronckers A.L., Gortzak R.A., Hogendoorn P.C., van der Wee-Pals L., Balemans W., et al. Sclerostin in mineralized matrices and van Buchem disease. JDent Res 2009, 88(6):569-574.
28. Karlsson C., Dehne T., Lindahl A., Brittberg M., Pruss A., Sittinger M., et al. Genome-wide expression profiling reveals new candidate genes associated with osteoarthritis. Osteoarthritis Cartilage 2010, 18(4):581-592.
29. Ding M., Danielsen C.C., Hvid I. Effect of hyaluronan on three-dimensional microarchitecture of subchondral bone tissues in guinea pig primary osteoarthrosis. Bone 2005, 36(3):489-501.
30. Bellido M., Lugo L., Roman-Blas J.A., Castañeda S., Caeiro J.R., Dapia S., et al. Subchondral bone microstructural damage by increased remodelling aggravates experimental osteoarthritis preceded by osteoporosis. Arthritis Res Ther 2010, 12(4):R152.
31. Tat S.K., Pelletier J.P., Velasco C.R., Padrines M., Martel-Pelletier J. New perspective in osteoarthritis: the OPG and RANKL system as a potential therapeutic target?. Keio J Med 2009, 58(1):29-40.
32. Tat S.K., Pelletier J.P., Lajeunesse D., Fahmi H., Lavigne M., Martel-Pelletier J. The differential expression of osteoprotegerin (OPG) and receptor activator of nuclear factor kappaB ligand (RANKL) in human osteoarthritic subchondral bone osteoblasts is an indicator of the metabolic state of these disease cells. Clin Exp Rheumatol 2008, 26(2):295-304.
33. Zhu S., Chen K., Lan Y., Zhang N., Jiang R., Hu J. Alendronate protects against articular cartilage erosion by inhibiting subchondral bone loss in ovariectomized rats. Bone 2013, 53(2):340-349.
34. Agarwal S., Misra R., Aggarwal A. Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. Rheumatol Int 2009, 29(8):907-911.
35. Sanchez C., Gabay O., Salvat C., Henrotin Y.E., Berenbaum F. Mechanical loading highly increases IL-6 production and decreases OPG expression by osteoblasts. Osteoarthritis Cartilage 2009, 17(4):473-481.
36. Upton A.R., Holding C.A., Dharmapatni A.A., Haynes D.R. The expression of RANKL and OPG in the various grades of osteoarthritic cartilage. Rheumatol Int 2012, 32(2):535-540.